ASK REDCHAT ANYTHING ABOUT LONGEVERON INC.
Longeveron Inc. (NASDAQ: LGVN)
Listen to this Section
$0.75
-0.0550
(
-6.87% )
209.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Lomecel-BDetailsHypoplastic Left Heart Syndrome |
Phase 2a |
| Lomecel-BDetailsAlzheimer's disease |
Phase 2a |
| Lomecel-BDetailsAging Frailty |
Failed |
| Lomecel-BDetailsAcute respiratory distress syndrome |
Failed |
Market Data
|
| Open |
$0.75 |
| Previous Close |
$0.80 |
| Volume |
209.2K |
| Market Cap |
$25.28M |
| Day Range |
$0.74 - $0.81 |
| 52 Week Range |
$0.48 - $1.80 |
| Shares Outstanding |
31.60M |
| Change % |
-6.87% |
| Net Change |
▼ -0.0550 |
| Insider Ownership |
-0.11% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Medicinal Chemicals and Botanical Products |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-147,813.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-09-06 |
Sale |
-4323.00 |
Hashad Mohamed Wa'el Ahmed |
| 2023-08-22 |
Sale |
-3081.00 |
Agafonova Nataliya |
| 2023-08-22 |
Sale |
-767.00 |
Lehr Paul T |
| 2023-08-22 |
Sale |
-4292.00 |
Hashad Mohamed Wa'el Ahmed |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
12 |
Nov 12, 2025 |
| 8-k |
8K-related |
14 |
Nov 04, 2025 |
| 10-q |
Quarterly Reports |
69 |
Nov 04, 2025 |
| 4 |
Insider transactions |
1 |
Oct 27, 2025 |
| 3 |
Insider transactions |
2 |
Oct 27, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |